[Liver transplantation for primary biliary cirrhosis: retrospective analysis of 52 patients in QLTS]

Zhonghua Gan Zang Bing Za Zhi. 2004 Sep;12(9):543-5.
[Article in Chinese]

Abstract

Objective: Retrospectively analyzing post-transplant primary biliary cirrhosis patients to document the actual survival time, the cause of post-transplant death, and recurrences after liver transplantation in patients followed up by the Queensland Liver Transplant Service (QLTS).

Methods: The case notes of all post-piggyback liver transplantation patients followed up by QLTS were reviewed. We analyzed the clinical characteristics of the PBC patients, post-transplant actual survival rates, the causes of post-transplant death, and risk factors of recurrence, and compared the survival rates between patients with and without liver transplantation using a European model.

Results: Fifty-two post-transplant patients with 54 transplantations were identified with an average age of 53 years and a mean follow-up time of 55 months. The actual survival times of PBC patients with grafts for 1 years, 5 years and 10 years were 88.4%, 80.1%, 76.9% and 80.9%, 65.4%, 19.8%. The causes of death were MOF intra-abdominal bleeding, renal failure, sepsis and cardiovascular diseases. Comparing the survival rates between with and without transplantation, 8.5% of PBC patients have recurrences with an average recurrent time of 34 months.

Conclusion: (1) Liver transplantation could improve survival rates, but the optimum time for transplantation should be focused on; (2) A long-term and larger follow-up sampling should be done to understand the effects of recurrences on patient's long-term survival; (3) CsA may play a more important role in preventing recurrence of PBC than Tacrolimus

Publication types

  • English Abstract

MeSH terms

  • Cyclosporine / therapeutic use*
  • Female
  • Follow-Up Studies
  • Graft Rejection / prevention & control
  • Humans
  • Liver Cirrhosis, Biliary / surgery*
  • Liver Transplantation* / mortality
  • Male
  • Middle Aged
  • Postoperative Period
  • Retrospective Studies
  • Secondary Prevention
  • Survival Rate
  • Treatment Outcome

Substances

  • Cyclosporine